Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021

Sera were collected from 185 adults aged ≥ 70 years in London to evaluate the immune response to COVID-19 vaccines. A single dose of Pfizer/BioNtech vaccine resulted in > 94% seropositivity after 3 weeks in naïve individuals using the Roche Spike antibody assay, while two doses produced very high...

Descripción completa

Detalles Bibliográficos
Autores principales: Subbarao, Sathyavani, Warrener, Lenesha A, Hoschler, Katja, Perry, Keith R, Shute, Justin, Whitaker, Heather, O’Brien, Michelle, Baawuah, Frances, Moss, Paul, Parry, Helen, Ladhani, Shamez N, Ramsay, Mary E, Brown, Kevin E, Amirthalingam, Gayatri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2021
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995559/
https://www.ncbi.nlm.nih.gov/pubmed/33769252
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.12.2100329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995559/
https://www.ncbi.nlm.nih.gov/pubmed/33769252
http://dx.doi.org/10.2807/1560-7917.ES.2021.26.12.2100329

Ejemplares similares